Anaplastic Oligoastrocytoma

Search Trials
Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
Status:
Completed
Last Changed:
Oct 22, 2020
First Changed:
Jan 27, 2003
Disease(s):
Brain and Central Nervous System Tumors
Intervention(s):
temozolomideneoadjuvant therapyradiation therapy
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
Status:
Completed
Last Changed:
Aug 1, 2018
First Changed:
May 16, 2008
Disease(s):
Childhood High-grade Cerebellar Astrocytoma
Intervention(s):
cilengitidelaboratory biomarker analysispharmacological study
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Status:
Completed
Last Changed:
Oct 4, 2016
First Changed:
Feb 1, 2012
Disease(s):
Anaplastic Astrocytoma
Intervention(s):
DEC-205/NY-ESO-1 Fusion Protein CDX-1401Laboratory Biomarker AnalysisPharmacological StudySirolimus
Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
Status:
Terminated
Last Changed:
May 30, 2016
First Changed:
Jan 9, 2014
Disease(s):
Recurrent Childhood Anaplastic Astrocytoma
Intervention(s):
oncolytic HSV-1716dexamethasonetherapeutic conventional surgerylaboratory biomarker analysis

Connect. Empower. Inspire.